COMPASS Pathways Price to Free Cash Flow Ratio 2019-2025 | CMPS

COMPASS Pathways price to free cash flow ratio from 2019 to 2025. Price to free cash flow ratio can be defined as

COMPASS Pathways Price to Free Cash Flow Ratio 2019-2025 | CMPS

COMPASS Pathways price to free cash flow ratio from 2019 to 2025. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$139.4B
CVS Health (CVS)$80.1B
Elevance Health (ELV)$68.3B
Cencora (COR)$57.1B
DiDi Global (DIDIY)$27.2B
Labcorp Holdings (LH)$20.7B
Natera (NTRA)$19.6B
BioMerieux (BMXMF)$16.9B
EUROFINS SCIENT (ERFSF)$13.9B
CochLear (CHEOY)$13.1B
Solventum (SOLV)$12.8B
ICON (ICLR)$11.9B
Revvity (RVTY)$11.3B
Viatris (VTRS)$10.9B
Medpace Holdings (MEDP)$9.2B
Avantor (AVTR)$9.1B
Sonic Healthcare (SKHHY)$8.8B
HealthEquity (HQY)$8.7B
Caris Life Sciences,�Inc (CAI)$8B
Charles River Laboratories (CRL)$7.7B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.2B
Surgery Partners (SGRY)$2.9B
Alignment Healthcare (ALHC)$2.6B
Concentras Parent (CON)$2.5B
Organon (OGN)$2.5B
GeneDx Holdings (WGS)$2.3B
Progyny (PGNY)$2B